Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients.

Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.

Clinical Trials

Health Care

Medical Devices

Segal Trials

Scott D. Segal

Michelle Amankwah

Meredith Auerbach

Kimberly Gardner-Williams

Ernesto Alfonso

Ephraïm Floréal

Barbara Y Valero Lopez

Alan Arredondo

Samantha Garcia

Maria Bolivar

Daniela Chueke

Melissa Gianos

Tabatha Cirgenski-Ruiz

Kadeeja Whyte

Charlie Small

Rishi Kakar

Kavoia Smalls

Danielle Recasens

Bonnie Segal

Human Resources and Recruitment

Clinical Research Team

Leadership Team

Operations Team

Clinical and Regulatory Affairs

Marketing Team

Teams at Segal Trials